ABK Biomedical celebrates construction kickoff of their future home
Collaboration brings together ABK Biomedical, COR Development, Coil Construction and the University of Missouri and MU Research Reactor to advance innovative liver cancer treatment technology ASHLAND, Mo., Oct. 2, 2026 /PRNewswire/ -- ABK Biomedical Inc. marked another significant...
Covered in this story
What has happened since
- Cencora is up 11.1% since this was published, 18 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Cencora
- RBC Capital Markets: $325 → $330 by Sep 2027 · Sector Perform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $COR yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Cencora →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.